Browse: Companies | People | Financial Organizations
Home > Financial Organizations > GIMV

General Information

Websitegimv.com
Phoneinfo@gimv.com
Employees
DescriptionIndependent investment company

Funds

Offices

People

Vice-Chairman
Chairman
Chief Executive Officer
Executive Vice President Technology
Partner Technology
Partner Technology
Partner Technology
Partner Technology
Partner Technology

Tags

GIMV

With more than 25 years of investment experience, Gimv is a Belgium-based private equity and venture capital provider and a major European and international market player. The company is listed on Euronext Brussels.

Both in Belgium and abroad, Gimv makes venture capital investments in promising high-tech companies. Gimv also focuses on buyouts and growth financing, to support companies’ development and growth. To target specific growth markets and particular asset types, Gimv cooperates with experienced parties to establish funds and joint ventures.

Milestones

Investments

Company Date Round Size Participants
GreenPeak Technologies 10/09Series B$19M5
Endosense 10/09Series B$36M7
Ubidyne 8/09Series B$43M4
VirtenSys 8/09Series C$16M3
Eclipse International 4/09Series A€3M1
Prosensa 12/08Series B€18M2
Clear2Pay 12/08Unattributed$8.27M4
Openbravo 4/08Series B$12M3
CoreOptics 4/08Unattributed$25M8
ChemoCentryx 3/07Series D$29.8M5
CoreOptics 7/06Unattributed$28M6
ChemoCentryx 6/04Unattributed$33M5

Videos

Sources

  1. GreenPeak secures €13M (US$19M) in Series B funding (greenpeak.com) [edit]
  2. Endosense, SA: Series B $36M (onbiovc.com) [edit]
  3. Ubidyne Secures $14.4 Million from Gimv and Current Investors to Complete $43 Million Series B Financing (freshnews.com) [edit]
  4. VirtenSys Raises $16 Million in New Round of Funding (freshnews.com) [edit]
  5. LUMA™ a powerful weapon in times of crisis (eclipseinternational.eu) [edit]
  6. Prosensa raises EUR 18 million Series B financing (hollandrijnland.regiovizier.nl) [edit]
  7. Clear2Pay enjoys unparalleled commercial momentum and raises €6 million in internal round (clear2pay.com) [edit]
  8. Openbravo Picks Up $12m Second Round (opensource.sys-con.com) [edit]
  9. CoreOptics Lands $25M (lightreading.com) [edit]
  10. ChemoCentryx, autoimmune disease drug co., raises $29.84M (deals.venturebeat.com) [edit]
  11. CoreOptics Nabs Another $28M (lightreading.com) [edit]
  12. ChemoCentryx Raises $33 Million in Private Financing (chemocentryx.com) [edit]
Edit This Page
Last Edited 10/29/09

Revision History RSS Picture

Recent Incoming Links

External Links

Embed Widget

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy